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Early Dengue Virus Infection in
Human Skin: A Cycle of Inﬂammation
and Infectivity
Matthew O. Ivory1,2, James C. Birchall2 and Vincent Piguet1
Early events during dengue virus (DENV) infection remain poorly understood. In
this issue, Schaeffer and colleagues employ ex vivo human skin cells to
investigate viral infection. They show that skin-resident immune cells are
infected by DENV and that their infectability is increased in the inﬂammatory skin
conditions (especially those in which IL-4 is released) that accompany the
mosquito bites transmitting the virus.
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Dengue virus (DENV) is a single-strand
positive RNA virus, and it is the most
common arthropod-transmitted virus
(arbovirus) that is transmitted to humans
exclusively via Aedes mosquitos. Den-
gue viral infection presents most com-
monly with fever, muscle/joint pains,
and headache that are often accompa-
nied by a characteristic rash. Serious
infection can progress to hemorrhagic
dengue fever or dengue shock syn-
drome, which may lead to death via
hemorrhage and hypovolemic shock,
respectively. Neither vaccines nor spe-
ciﬁc antiviral treatments are available,
and the World Health Organization
estimates that almost half of the world’s
population are currently at a risk for the
disease. The potential severity of symp-
toms, signiﬁcant at-risk population, and
lack of effective treatments have led to
dengue disease being named as one of
the Bill and Melinda Gates Foundation’s
“neglected” tropical diseases that
require an increase in research to
improve global health. In the search
for new treatment/prevention strategies,
improved understanding of the viral
pathogenesis is essential. The study by
Schaeffer et al. (2015) in this issue
employs an ex vivo human skin cell
model to further our understanding of
DENV infection.
As DENV is transmitted via mosquito
bites, the skin is the primary site of
infection. Human skin contains a variety
of immunological cells, including Lan-
gerhans cells (LCs) in the epidermis, and
subsets of dermal dendritic cells (DCs),
along with macrophages and T cells, in
the dermis. These cells will be among the
ﬁrst to encounter the virus following
transmission. Both LCs and DCs have
been shown previously to be infected by
DENV (Cerny et al., 2014). In their study,
Schaeffer et al. (2015) investigated the
interactions between DENV and dermal
DCs and macrophages under normal
conditions and in a model of inﬂam-
mation. Dermal DCs, unlike LCs, are
heterogeneous. Three subsets are com-
monly cited in the literature: CD14+,
CD1c+, and CD141+ DCs (Chu et al.,
2012 and Haniffa et al., 2012). Each
subset possesses individual properties
in terms of viral infectability, antigen
processing, and immune response
stimulation. Schaeffer et al. (2015) focus
on CD14+ and CD1c+ DCs alongside
dermal macrophages to determine their
susceptibility to infection following viral
entry into the skin.
C-type lectins such as Langerin
(CD207), dendritic cell-Speciﬁc Inter-
cellular adhesion molecule-3-grabbing
non-integrin (DC-SIGN; CD209), and
mannose receptor (MR/CD206) enable
immunological cells to take up antigen
from the extracellular environment
(Engering et al., 2002 and de Witte
et al., 2007). This method of uptake is
exploited by a number of viruses, such
as HIV-1 and DENV, to gain entry into
the cell that they can subsequently
infect (Arrighi et al., 2004). The role of
DC-SIGN in DENV pathogenesis has
been conﬁrmed through the study of
patients with certain DC-SIGN poly-
morphisms and who possess a higher
risk of developing dengue hemorrhagic
fever following viral infection
(Sakuntabhai et al., 2005).
Given the proposed role of DC-SIGN
in DENV infection, Schaeffer et al.
(2015) initially determined the effect of
skin inﬂammation on the number of
DC-SIGN+ cells, using bullous pemphi-
goid, hypereosinophilic syndrome, masto-
cytosis, and scabies infection-affected skin
as models for mosquito-bitten skin, on the
basis of shared properties of basophil
recruitment and eosinophilia. It was found
that all of the inﬂammatory conditions
studied possessed higher numbers of DC-
SIGN+ cells in the skin, when compared
with non-inﬂammed skin, leading the
authors to suggest that the inﬂammation
arising from a mosquito bite might
enhance the recruitment of cells available
for infection at the site.
Schaeffer et al. (2015) obtained skin
DCs (along with other migratory cells)
using a well-established migratory cell
protocol (Chu et al., 2012). Cells were
infected in an unsorted state, then the
infection levels were determined via
ﬂow cytometry. They found that all of
the skin DC subsets could be infected
by DENV, with infectability being
highest in CD14+ dermal DCs and
lowest in LCs, with higher DC-SIGN
expression in CD14+ cells suggested as
a reason for this difference. The low
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infectability of LCs found by Schaeffer
et al. (2015) contradicts a previous
study that found LCs to be the most
susceptible skin immune cell to DENV
infection (Cerny et al., 2014).
Transmission of arboviruses is
accompanied by trauma at the local
site, as well as the delivery of insect
salivary substances, which can elicit an
inﬂammatory response in isolation. It is
speculated that the Th2-type immune
response that occurs following insect
bites leads to increased rates of infec-
tion and clinical symptoms from DENV
(Cox et al., 2012). Schaeffer et al. (2015)
focused on IL-4, which is released
from basophils, mast cells, and T cells
during the immune response to foreign
antigens, to determine whether
inﬂammation from the mosquito bite
promotes viral infection of cutaneous
immune cells. Exposing DCs to IL-4 led
to a marked increase in CD14+ DC
infection rates with the virus, but with
little effect on other DCs/LCs, suggesting
that CD14+ cell infection may become
prominent following mosquito bite
inﬂammation. Incubation of dermal
DCs with IL-4 also enhanced their
T-cell stimulatory ability as evidenced
by proliferation of carboxyﬂuorescein
succinimidyl ester-labeled naive T cells
following co-culture. Their presence in
the skin and expression of the C-type
lectin MR make macrophages a cell
population potentially susceptible to
DENV infection. Dermal macrophage
infection was studied following enzy-
matic digestion and cell sorting of skin
specimens. This allowed the investiga-
tors to obtain a population of CD14+
macrophages; the investigators specu-
late that CD14+ DCs may have
developed a macrophage-like pheno-
type in culture. It was found that IL-4,
with or without GM-CSF, also increased
their susceptibility to DENV infection.
Infection led to the release of tumor
necrosis factor (TNF-α), most markedly
in the macrophages with higher levels
of viral infection. This led the authors to
speculate that DENV infection of DCs
could lead to potent T-cell antiviral
responses, whereas macrophage infec-
tion would most likely lead to the
symptoms of inﬂammation associated
with DENV infection.
Schaeffer et al. (2015) reason that
because CD14+ DCs are most readily
infected, especially under inﬂammatory
conditions, and because they tend to
generate humoral immune responses,
these cells are likely to be responsible
for the increased severity of DENV
disease upon subsequent exposure to a
different serotype of the virus. This
occurs because of cross-reactive anti-
bodies that can bind to other DENV
serotypes without fully neutralizing
them, instead facilitating their entry into
immune cells and leading to more
severe infection (Endy et al., 2004).
This could represent an important
subject of further study, as moderating
this response might lower the risk of
serious DENV disease. The release of
TNF-α by macrophages in the dermis,
especially when exposed to IL-4, is also
likely to be important because of the
cytokine’s proposed central role in the
development of dengue fever. It is also
likely that the local inﬂammation
caused by TNF-α release would lead
to the release of IL-4, creating a cycle of
increasing rates of infection by the local
immune cells.
The studies reported by Schaeffer
et al. (2015) build upon earlier animal
studies that have shown an increase in
arbovirus infection rates because of
simultaneous immune responses to
mosquito salivary substances, but it
widens the focus by employing
primary human skin cells, a model that
resembles arboviral infection more
closely. Understanding how DENV
can take advantage of inﬂammatory
conditions for its propagation may
reveal novel opportunities to block this
virus when invading hosts via skin
immune cells.
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Clinical Implications
● Aedes mosquito bites lead to local inﬂammation, which results in the
release of IL-4. This cytokine increases the infectability of both dermal
dendritic cells (DCs) and dermal macrophages.
● CD14+ DCs are the most readily infected cells, and they are likely to be
important in driving humoral immune responses against DENV.
● Dermal macrophages release TNF-α upon DENV infection, driving local
inﬂammation and further increasing the infectability of skin immune
cells.
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